Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Randomised, Placebo-controlled, Double Blinded, Parallel Arm Proof-of-concept Trial of Lixisenatide in Patients With Early Parkinson's Disease

NCT03439943 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT03439943
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03439943 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Randomised, Placebo-controlled, Double Blinded, Parallel Arm Proof-of-concept Trial of Lixisenatide in Patients With Early Parkinson's Disease
Lead sponsor
University Hospital, Toulouse
Phase
Phase 2
Overall status
Completed
Start date
June 13, 2018
Completion date
April 15, 2021
Enrollment
156 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease